TY - JOUR
T1 - A joint procedural position statement on imaging in cardiac sarcoidosis
T2 - From the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology
AU - Writing group
AU - Document reading group
AU - EACVI Scientific Documents Committee for 2014-2016 and 2016-2018
AU - Slart, Riemer H.J.A.
AU - Glaudemans, Andor W.J.M.
AU - Lancellotti, Patrizio
AU - Hyafil, Fabien
AU - Blankstein, Ron
AU - Schwartz, Ronald G.
AU - Jaber, Wael A.
AU - Russell, Raymond
AU - Gimelli, Alessia
AU - Rouzet, François
AU - Hacker, Marcus
AU - Gheysens, Olivier
AU - Plein, Sven
AU - Miller, Edward J.
AU - Dorbala, Sharmila
AU - Donal, Erwan
AU - Sciagra, Roberto
AU - Bucerius, Jan
AU - Verberne, Hein J.
AU - Lindner, Oliver
AU - Übleis, Christopher
AU - Agostini, Denis
AU - Signore, Alberto
AU - Edvardsen, Thor
AU - Neglia, Danilo
AU - Beanlands, Rob S.
AU - Di Carli, Marcelo
AU - Chareonthaitawee, Panithaya
AU - Dilsizian, Vasken
AU - Soman, Prem
AU - Habib, Gilbert
AU - Delgado, Victoria
AU - Cardim, Nuno
AU - Cosyns, Bernard
AU - Flachskampf, Frank
AU - Gerber, Bernhard
AU - Haugaa, Kristina
AU - Lombardi, Massimo
AU - Masci, Pier Giorgio
N1 - Funding Information:
18LTSI, Université de Rennes 1 - INSERM, UMR 1099, - Rennes, France; 19Nuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy; 20Department of Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands; 21Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, The Netherlands; 22Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany; 23Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands; 24Institute of Radiology, Nuclear Medicine and Molecular Imaging, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany; 25Department of Clinical Radiology, Ludwig-Maximilians Universit€at München, München, Germany; 26Department of Nuclear Medicine, CHU Cote de Nacre, CAEN, France; 27Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, ‘Sapienza’ University of Roma, Rome, Italy; 28Department of Cardiology, Oslo University Hospital, Rikshospitalet and University of Oslo, Oslo, Norway; 29Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada; 30Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA; 31Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; 32Division of Cardiology, Heart and Vascular Institute, University of Pittsburgh Medical Center, A-429 Scaife Hall, 200 Lothrop Street, Pittsburgh, PA, 15213, USA; and 33Department of Cardiology, Aix-Marseille Université, Marseille 13284, France La Timone Hospital, 13005, Marseille, France
Publisher Copyright:
© The Author 2017.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - This joint position paper illustrates the role and the correct use of echocardiography, radionuclide imaging with 18 F-fluorodeoxyglucose positron emission tomography, radionuclide myocardial perfusion imaging and cardiovascular magnetic resonance imaging for the evaluation and management of patients with known or suspected cardiac sarcoidosis. This position paper will aid in standardizing imaging for cardiac sarcoidosis and may facilitate clinical trials and pooling of multi-centre data on cardiac sarcoidosis. Proposed flow charts for the work up and management of cardiac sarcoidosis are included.
AB - This joint position paper illustrates the role and the correct use of echocardiography, radionuclide imaging with 18 F-fluorodeoxyglucose positron emission tomography, radionuclide myocardial perfusion imaging and cardiovascular magnetic resonance imaging for the evaluation and management of patients with known or suspected cardiac sarcoidosis. This position paper will aid in standardizing imaging for cardiac sarcoidosis and may facilitate clinical trials and pooling of multi-centre data on cardiac sarcoidosis. Proposed flow charts for the work up and management of cardiac sarcoidosis are included.
UR - http://www.scopus.com/inward/record.url?scp=85041211726&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041211726&partnerID=8YFLogxK
U2 - 10.1093/ehjci/jex146
DO - 10.1093/ehjci/jex146
M3 - Article
C2 - 28984894
AN - SCOPUS:85041211726
SN - 2047-2404
VL - 18
SP - 1073
EP - 1089
JO - European heart journal cardiovascular Imaging
JF - European heart journal cardiovascular Imaging
IS - 10
ER -